Skip to content
Screener

Integra LifeSciences IART Other Income (Expense)

Other Income (Expense) at other companies

Stryker logo
StrykerSYK
-$95M+2.1%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
-$2.25M-55.5%
Axogen logo
AxogenAXGN
$640K+159%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$35K-975%
MiMedx Group logo
MiMedx GroupMDXG
-$102K-1.0%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
-$396K+55.4%

Other financials

Income statement

See full
Revenue$418.8M+0.8%
Gross profit$219.7M+5.0%
Operating income$19.3M+104%
Net income$4.5M+101%
EPS (diluted)$0.06+101%

Balance sheet

See full
Cash & equivalents$214.4M-1.6%
Total debt$2.0B+3.2%
Total equity$1.0B+0.5%
Total assets$3.6B-2.8%

Cash flow

See full
Operating cash flow$22.8M+156%
CapEx$12.3M-38.9%
Free cash flow$10.5M+193%

Valuation

See full
Market cap$1.33B+38.0%
Enterprise value$3.08B+16.2%
P/S0.8×+0.2×

Profitability

See full
Gross margin52.5%-0.1pp
Operating margin2.6%+1.3pp
Net margin-0.4%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-0.7%
Debt / equity1.9×+0.1×
Current ratio3.6×+2.4×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000917520-26-000058
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Operating income (loss)19,285(512,674)30,755(528,171)
Interest income4,2674,7108,3729,130
Interest expense(22,994)(21,042)(45,459)(39,857)
Other income (expense), net4,186(1,946)8,665(2,090)
Income (loss) before income taxes4,744(530,952)2,333(560,988)
Provision (benefit) for income taxes262(46,879)2,467(51,622)
Net income (loss)$4,482$(484,073)$(134)$(509,366)
Net income (loss) per share

Item 1. Financial Statements

FAQ

What is Integra LifeSciences's other income (expense)?
Integra LifeSciences (IART) reported other income (expense) of $4.19M in Q2 2026.
How has Integra LifeSciences's other income (expense) changed year-over-year?
Integra LifeSciences's other income (expense) increased by 315.1% year-over-year, from -$1.95M to $4.19M.
What is the long-term trend for Integra LifeSciences's other income (expense)?
Over 3 years (2021 to 2024), Integra LifeSciences's other income (expense) has grown at a -41.1% compound annual growth rate (CAGR), from $19.31M to $3.94M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Integra LifeSciences's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude